Detalhe da pesquisa
1.
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Cancer
; 130(10): 1747-1757, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236702
2.
Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE.
Br J Cancer
; 130(8): 1348-1355, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347093
3.
ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients.
Cancer Cell Int
; 23(1): 165, 2023 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568162
4.
Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112.
J Natl Compr Canc Netw
; 21(9): 915-923.e1, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37673107
5.
Targeting progesterone signaling prevents metastatic ovarian cancer.
Proc Natl Acad Sci U S A
; 117(50): 31993-32004, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262282
6.
In vivo modeling of metastatic human high-grade serous ovarian cancer in mice.
PLoS Genet
; 16(6): e1008808, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32497036
7.
Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).
Cancer
; 128(11): 2174-2181, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285940
8.
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
Lancet Oncol
; 22(2): 212-222, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33460574
9.
Tolerability of bevacizumab and chemotherapy in a phase 3 clinical trial with human epidermal growth factor receptor 2-negative breast cancer: A trajectory analysis of adverse events.
Cancer
; 127(24): 4546-4556, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726788
10.
Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
Radiology
; 301(1): 66-77, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342501
11.
Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial.
Cancer
; 126(1): 211-218, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31539169
12.
Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
JAMA
; 323(8): 746-756, 2020 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096852
13.
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.
Breast Cancer Res
; 21(1): 87, 2019 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31383035
14.
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.
Breast Cancer Res
; 20(1): 82, 2018 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30071865
15.
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study.
Br J Cancer
; 119(9): 1086-1093, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361524
16.
Impact of primary breast cancer therapy on energetic capacity and body composition.
Breast Cancer Res Treat
; 172(2): 445-452, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30136009
17.
Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial.
Support Care Cancer
; 26(6): 1993-2004, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327085
18.
Metastatic breast cancer patients' expectations and priorities for symptom improvement.
Support Care Cancer
; 26(11): 3781-3788, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29736866
19.
Survival benefit needed to undergo chemotherapy: Patient and physician preferences.
Cancer
; 123(15): 2821-2828, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28323331
20.
Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?
Breast Cancer Res Treat
; 165(3): 545-553, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28646344